Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and isotretinoin

erlotinib hydrochloride has been researched along with isotretinoin in 4 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(isotretinoin)		Trials
(isotretinoin)		Recent Studies (post-2010) (isotretinoin)
4,3537863,0334,0645061,216

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)isotretinoin (IC50)
Adenosine receptor A3Homo sapiens (human)4.169
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)4.169
Alpha-2B adrenergic receptorHomo sapiens (human)6.612
Mitogen-activated protein kinase 1Homo sapiens (human)0.462
Cellular retinoic acid-binding protein 1Gallus gallus (chicken)0.9
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.848
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)4.169
Mitogen-activated protein kinase 14Homo sapiens (human)2.529
Olfactory receptor 51E2Homo sapiens (human)0.16

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altomare, G; Bidoli, P; Cazzaniga, ME; Cicchiello, F; Colombo, I; Cortinovis, DL; Crippa, A; Villa, F1
Llombart, B; Requena, C; Sanmartín, O1
Liu, J; Xie, A1
Ezzedine, K1

Reviews

2 review(s) available for erlotinib hydrochloride and isotretinoin

ArticleYear
Chemoprevention of oral cancer in leukoplakia patients: A systematic review and meta-analysis.
    JPMA. The Journal of the Pakistan Medical Association, 2017, Volume: 67, Issue:9

    Topics: Antineoplastic Agents; beta Carotene; Chemoprevention; Erlotinib Hydrochloride; Humans; Isotretinoin; Leukoplakia, Oral; Mouth Neoplasms; Precancerous Conditions; Provitamins; Tea; Treatment Outcome; Vitamin A; Vitamins

2017
[What's new in dermatological therapy?]
    Annales de dermatologie et de venereologie, 2016, Volume: 143 Suppl 3

    Topics: Adalimumab; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Dermatology; Erlotinib Hydrochloride; Herpes Zoster Vaccine; Humans; Interleukin 1 Receptor Antagonist Protein; Isotretinoin; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin Diseases; Trimethoprim, Sulfamethoxazole Drug Combination

2016

Other Studies

2 other study(ies) available for erlotinib hydrochloride and isotretinoin

ArticleYear
Isotretinoin plus clindamycin seem highly effective against severe erlotinib-induced skin rash in advanced non-small cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010, Volume: 5, Issue:10

    Topics: Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clindamycin; Dermatologic Agents; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Humans; Isotretinoin; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Survival Rate; Treatment Outcome

2010
Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.
    Cutis, 2012, Volume: 90, Issue:2

    Topics: Acneiform Eruptions; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Dermatologic Agents; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Isotretinoin; Male; Quinazolines

2012